From: Development, optimization, and in vitro evaluation of atorvastatin calcium and vinpocetine codelivery by solid lipid nanoparticles for cancer therapy
Formulations
Hep-G2 (µg/ml)
MCF 7 (µg/ml)
Melanoma (B16 F10) µg/ml
Free ATS
17.71
26.62
29.22
Free VIN
10.51
273.1
252.0
ATS SLNs
17.12
41.91
4.17
VIN SLNs
2.85
59.31
12.51
SLNs
1.04
12.97
8.06